Mirum Pharmaceuticals has partnered with PreventionGenetics to offer a no-cost genetic testing program to help identify the genetic cause of cholestasis through a 77-gene panel. This program is available to US resident who meet eligibility criteria and must be ordered by a qualified healthcare provider.
